CHINA HEALTH (00673) announces annual results, with a net loss attributable to owners of 47.932 million Hong Kong dollars, a year-on-year decrease of 29.29%.
China Health Group (00673) announced its annual performance for the year ending March 31, 2026, with a revenue of HK$41.092 million, a year-on-year increase of 5.52%; the company's attributable loss was HK$47.932 million, a year-on-year reduction of 29.29%; the loss per share was HK$0.0496.
CHINA HEALTH (00673) announced its financial results for the year ending March 31, 2026. The company reported a revenue of HK$41.09 million, representing a year-on-year increase of 5.52%. The company's attributable loss was HK$47.93 million, narrowing by 29.29% compared to the previous year. The loss per share was HK$0.0496.
Related Articles
COSCO SHIPPING Development(02866) plans to invest 8.656 billion yuan to acquire a total of 24 vessels.
REALWAY CAPITAL(01835): Change of controlling shareholder, offering a cash offer of approximately 39.39% discount and will resume trading on July 2nd.
HUNLICAR GROUP (03638) announced its annual performance, with a net profit attributable to shareholders of HK$28.166 million.
COSCO SHIPPING Development(02866) plans to invest 8.656 billion yuan to acquire a total of 24 vessels.
REALWAY CAPITAL(01835): Change of controlling shareholder, offering a cash offer of approximately 39.39% discount and will resume trading on July 2nd.
HUNLICAR GROUP (03638) announced its annual performance, with a net profit attributable to shareholders of HK$28.166 million.
RECOMMEND
